Assignee
BIONTECH AG
DE·31 granted patents·17 pending applications·82 citations·filing 2008–2023
Top patents by PatentIndex Score
48 records- 0196US10106800B2Modification of RNA, producing an increased transcript stability and translation efficiencyBIONTECH AG·Filed 2016·Granted Oct 23, 2018·18 cites·11 claims
- 0292US9267177B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2015·Granted Feb 23, 2016·6 cites·7 claims
- 0390US10717780B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2018·Granted Jul 21, 2020·5 cites·12 claims
- 0487US10980875B2Cytotoxic immunostimulating particles and uses thereofBIONTECH AG·Filed 2016·Granted Apr 20, 2021·2 cites·13 claims
- 0587US9950065B2Particles comprising a shell with RNABIONTECH AG·Filed 2013·Granted Apr 24, 2018·12 cites·20 claims
- 0687US9533043B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Jan 3, 2017·7 cites·5 claims
- 0786US10604568B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2014·Granted Mar 31, 2020·6 cites·10 claims
- 0886US9194004B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Nov 24, 2015·6 cites·4 claims
- 0985US11787862B2Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseasesBIONTECH AG·Filed 2017·Granted Oct 17, 2023·3 cites·32 claims
- 1084US10724103B2Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapyBIONTECH AG·Filed 2017·Granted Jul 28, 2020·1 cites·3 claims
- 1184US10093736B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2013·Granted Oct 9, 2018·7 cites·9 claims
- 1280US11628209B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2018·Granted Apr 18, 2023·1 cites·15 claims
- 1379US10172960B2Particles comprising single stranded RNA and double stranded RNA for immunomodulationBIONTECH AG·Filed 2017·Granted Jan 8, 2019·1 cites·11 claims
- 1478US2024059772A1Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2023·Application pending·0 cites
- 1577US10253373B2Identification of tumor-associated markers for diagnosis and therapyBIONTECH AG·Filed 2017·Granted Apr 9, 2019·1 cites·5 claims
- 1676US10188712B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2014·Granted Jan 29, 2019·3 cites·7 claims
- 1774US2024228616A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2022·Application pending·0 cites
- 1871US11008550B2Use of RNA for reprogramming somatic cellsBIONTECH AG·Filed 2019·Granted May 18, 2021·0 cites·4 claims
- 1970US2022347308A1Methods and means for inducing an immune responseBIONTECH AG·Filed 2022·Application pending·0 cites
- 2069US10550430B2Method and kit for determining whether a subject shows an immune responseBIONTECH AG·Filed 2014·Granted Feb 4, 2020·1 cites·20 claims
- 2168US10858415B2Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2014·Granted Dec 8, 2020·1 cites·15 claims
- 2267US11795218B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2020·Granted Oct 24, 2023·0 cites·22 claims
- 2367US2019062762A1Modification of RNA, Producing an Increased Transcript Stability and Translation EfficiencyBIONTECH AG·Filed 2018·Application pending·0 cites
- 2466US9910043B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2016·Granted Mar 6, 2018·0 cites·7 claims
- 2565US10302647B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2016·Granted May 28, 2019·0 cites·8 claims
- 2665US2020031898A1Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2019·Application pending·0 cites
- 2765US2020399370A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2020·Application pending·0 cites
- 2864US10370433B2Compositions and methods for diagnosis and treatment of cancerBIONTECH AG·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 2964US9637794B2Genetic products differentially expressed in tumors and use thereofBIONTECH AG·Filed 2013·Granted May 2, 2017·0 cites·10 claims
- 3063US9139880B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2013·Granted Sep 22, 2015·0 cites·7 claims
- 3162US2014134201A1Recombinant vaccines and use thereofBIONTECH AG·Filed 2014·Application pending·0 cites
- 3261US9617321B2Tumor vaccination involving a humoral immune response against self-proteinsBIONTECH AG·Filed 2014·Granted Apr 11, 2017·0 cites·20 claims
- 3360US10626400B2Stabilised formulations of RNABIONTECH AG·Filed 2014·Granted Apr 21, 2020·0 cites·10 claims
- 3460US9139639B2Polynucleotides encoding an intracellular segment of CD40 and a constant region of an immunoglobulin heavy chainBIONTECH AG·Filed 2014·Granted Sep 22, 2015·0 cites·14 claims
- 3559US9061007B2Compositions and methods for therapy and diagnosis of cancer and cancer metastasisBIONTECH AG·Filed 2013·Granted Jun 23, 2015·0 cites·9 claims
- 3658US2016002738A1Genetic products differentially expressed in tumors and use thereofBIONTECH AG·Filed 2015·Application pending·0 cites
- 3758US2017080068A1Identification of Tumor-Associated Antigens for Diagnosis and TherapyBIONTECH AG·Filed 2016·Application pending·0 cites
- 3857US10526387B2Tumor vaccination involving a humoral immune response against self-proteinsBIONTECH AG·Filed 2016·Granted Jan 7, 2020·0 cites·12 claims
- 3957US2017218342A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2017·Application pending·0 cites
- 4056US10457735B2Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domainsBIONTECH AG·Filed 2016·Granted Oct 29, 2019·0 cites·3 claims
- 4156US9944708B2Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)BIONTECH AG·Filed 2014·Granted Apr 17, 2018·0 cites·5 claims
- 4255US2018318436A1Methods and means for inducing an immune responseBIONTECH AG·Filed 2016·Application pending·0 cites
- 4354US2016215351A1Identification of Tumor-Associated Markers for Diagnosis and TherapyBIONTECH AG·Filed 2016·Application pending·0 cites
- 4453US2016122721A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2015·Application pending·0 cites
- 4550US2020340065A1Methods and kits for the molecular subtyping of tumorsBIONTECH AG·Filed 2020·Application pending·0 cites
- 4648US2015247206A1Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer MetastasisBIONTECH AG·Filed 2015·Application pending·0 cites
- 4746US2010267610A1Polypeptide comprising a knottin protein moietyBIONTECH AG·Filed 2008·Application pending·0 cites
- 4845US2017007776A1Cannula, an injection or infusion device and methods of using the cannula or the injection or infusion deviceBIONTECH AG·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BIONTECH AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →